GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quantum-Si Inc (NAS:QSI) » Definitions » COGS-to-Revenue

Quantum-Si (Quantum-Si) COGS-to-Revenue : 0.41 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Quantum-Si COGS-to-Revenue?

Quantum-Si's Cost of Goods Sold for the three months ended in Mar. 2024 was $0.19 Mil. Its Revenue for the three months ended in Mar. 2024 was $0.46 Mil.

Quantum-Si's COGS to Revenue for the three months ended in Mar. 2024 was 0.41.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Quantum-Si's Gross Margin % for the three months ended in Mar. 2024 was 58.86%.

Quantum-Si COGS-to-Revenue Historical Data

The historical data trend for Quantum-Si's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum-Si COGS-to-Revenue Chart

Quantum-Si Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
- - - - 0.55

Quantum-Si Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.62 0.52 0.56 0.41

Quantum-Si COGS-to-Revenue Calculation

Quantum-Si's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.594 / 1.082
=0.55

Quantum-Si's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.188 / 0.457
=0.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quantum-Si  (NAS:QSI) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Quantum-Si's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0.188 / 0.457
=58.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Quantum-Si COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Quantum-Si's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Quantum-Si (Quantum-Si) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quantum-Si Inc (NAS:QSI) » Definitions » COGS-to-Revenue
Comparable Companies
GRTS OBIO BIVI GLUE AKBA ALLK OTLK ATXS TCRX ALVR OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
530 Old Whitfield Street, Guilford, CT, USA
Website
https://www.quantum-si.com
Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.
Executives
Amir Jafri director C/O QUANTUM-SI INCORPORATED, 29 BUSINESS PARK DR., BRANFORD CT 06405
John P. Kenny director 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Jeffry R. Keyes officer: Chief Financial Officer 13950 STOWE DRIVE, POWAY CA 92064-8803
Scott Mendel director 5964 LA PLACE COURT, ADDRESS 2, CARLSBAD CA 92008
Christian Lapointe officer: General Counsel & Corp. Secr. C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Grace Johnston officer: Chief Commercial Officer C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Kevin Rakin director, officer: Chairman and CEO 36 CHURCH LANE, WESTPORT CT 06880
Jeffrey Alan Hawkins director, officer: Chief Executive Officer 5964 LA PLACE COURT, CARLSBAD CA 92008
Vikram Bajaj director 600 MONTGOMERY STREET, SUITE 4500, SAN FRANCISCO CA 94111
Jonathan M Rothberg director, 10 percent owner C/O BUTTERFLY NETWORK, INC., 530 OLD WHITFIELD ST., GUILFORD CT 06437
Matthew Dyer officer: Chief Business Officer C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Michael P Mckenna officer: President and COO C/O CURAGEN CORP, 555 LONG WHARF DR. 11TH FL., NEW HAVEN CT 06511
Patrick Schneider officer: President and COO C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
John Viii Stark director, officer: Chief Executive Officer C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
2012 Jmr Trust Common Llc 10 percent owner C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437